论文部分内容阅读
目的：本文探讨用导管经胃左动脉灌注化疗药治疗晚期贲门癌的疗效。材料与方法：其中36例作了122次动脉灌注化疗．结果：多数患者的临床症状如吞咽困难，上腹不适等得到缓解，半年生存率80．5％（29／36），1年生存率58．3％（21／36），2年生存率33．3％（12／36）．本组未见重要的共发症．结论：初步结果表明：选择性动脉灌注化疗治疗晚期贲门癌是一种安全而有效的姑息疗法．
OBJECTIVE: To investigate the efficacy of catheter-assisted transgastric arterial infusion of chemotherapy for the treatment of advanced cardiac cancer. Materials and Methods: Thirty-two patients received 122 arterial infusion chemotherapy. Results: Most patients had clinical symptoms such as dysphagia and epigastric discomfort. The half-year survival rate was 80.5% (29/36), the one-year survival rate was 58.3% (21/36), and the 2-year survival rate was 33. .3% (12/36). No major comorbidity was found in this group. Conclusion: Preliminary results indicate that selective arterial infusion chemotherapy is a safe and effective palliative treatment for advanced cardiac cancer.